- Home
- ISD vs TLRY Comparison
ISD vs TLRY Comparison
Compare ISD & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISD
- TLRY
- Stock Information
- Founded
- ISD 2012
- TLRY N/A
- Country
- ISD United States
- TLRY Canada
- Employees
- ISD N/A
- TLRY N/A
- Industry
- ISD Trusts Except Educational Religious and Charitable
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- ISD Finance
- TLRY Health Care
- Exchange
- ISD Nasdaq
- TLRY Nasdaq
- Market Cap
- ISD 472.3M
- TLRY 426.2M
- IPO Year
- ISD N/A
- TLRY 2018
- Fundamental
- Price
- ISD $14.19
- TLRY $0.69
- Analyst Decision
- ISD
- TLRY Hold
- Analyst Count
- ISD 0
- TLRY 2
- Target Price
- ISD N/A
- TLRY $1.38
- AVG Volume (30 Days)
- ISD 127.1K
- TLRY 44.7M
- Earning Date
- ISD 01-01-0001
- TLRY 07-28-2025
- Dividend Yield
- ISD 9.69%
- TLRY N/A
- EPS Growth
- ISD N/A
- TLRY N/A
- EPS
- ISD N/A
- TLRY N/A
- Revenue
- ISD N/A
- TLRY $826,656,000.00
- Revenue This Year
- ISD N/A
- TLRY $9.78
- Revenue Next Year
- ISD N/A
- TLRY $5.81
- P/E Ratio
- ISD N/A
- TLRY N/A
- Revenue Growth
- ISD N/A
- TLRY 11.22
- 52 Week Low
- ISD $10.98
- TLRY $0.35
- 52 Week High
- ISD $13.17
- TLRY $2.15
- Technical
- Relative Strength Index (RSI)
- ISD 59.49
- TLRY 60.33
- Support Level
- ISD $14.01
- TLRY $0.39
- Resistance Level
- ISD $14.14
- TLRY $0.83
- Average True Range (ATR)
- ISD 0.10
- TLRY 0.07
- MACD
- ISD -0.02
- TLRY 0.01
- Stochastic Oscillator
- ISD 63.33
- TLRY 58.38
About ISD PGIM High Yield Bond Fund Inc.
PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The Fund's investment objective is to provide a high level of current income. It invests at least 80% of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.